Alvogen has signed a definitive agreement to acquire County Line Pharmaceuticals, a specialty generic pharma company based in Wisconsin. The transaction diversifies Alvogen’s position in the U.S. and is expected to provide annual revenues of more than $100 million per year. The transaction is subject to customary regulatory conditions. Financial details were not disclosed.   County Line focuses on generic assets and specialty generic products and has a portfolio that spans multiple dosag...